Zoetis (ZTS) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ZTS Stock Forecast


Zoetis (ZTS) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $99.17, with a high of $160.00 and a low of $85.00. This represents a 34.83% increase from the last price of $73.55.

$50 $80 $110 $140 $170 $200 High: $160 Avg: $99.17 Low: $85 Last Closed Price: $73.55

ZTS Stock Rating


Zoetis stock's rating consensus is Hold, based on 31 Wall Street analysts. The breakdown includes 1 Strong Buy (3.23%), 13 Buy (41.94%), 17 Hold (54.84%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 31 17 13 1 Strong Sell Sell Hold Buy Strong Buy

ZTS Price Target Upside V Benchmarks


TypeNameUpside
StockZoetis34.83%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks8.86%

Price Target Trends


1M3M12M
# Anlaysts3819
Avg Price Target$89.67$93.00$118.05
Last Closing Price$73.55$73.55$73.55
Upside/Downside21.92%26.44%60.50%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26389--20
Jul, 26389--20
Jun, 26389--20
May, 26398--20
Apr, 26389--20
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2026Morgan Stanley$85.00$75.3012.88%15.57%
Jul 27, 2026UBS$85.00$76.5211.08%15.57%
Jul 22, 2026Morgan Stanley$99.00$75.5031.13%34.60%
Jul 06, 2026HSBC$95.00$74.6327.29%29.16%
Jul 01, 2026Barclays$85.00$71.9118.20%15.57%
Jun 26, 2026Stifel Nicolaus$85.00$77.829.23%15.57%
May 22, 2026Stifel Nicolaus$95.00$80.0618.66%29.16%
May 15, 2026Erin WrightMorgan Stanley$115.00$76.0651.20%56.36%
May 08, 2026UBS$99.00$83.2718.89%34.60%
May 08, 2026Stifel Nicolaus$105.00$87.3120.26%42.76%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Aug 06, 2026William BlairOutperformMarket Performdowngrade
May 15, 2026Morgan StanleyOverweightOverweighthold
Apr 15, 2026CitigroupBuyinitialise
Mar 10, 2026Leerink PartnersMarket PerformMarket Performhold
Mar 02, 2026William BlairOutperformOutperformhold
Feb 26, 2026BTIGBuyBuyhold
Jan 22, 2026Piper SandlerOverweightNeutraldowngrade
Dec 15, 2025Goldman SachsBuyupgrade
Dec 08, 2025BarclaysOverweightNeutralinitialise
Nov 20, 2025KeyBancSector Weightinitialise

Financial Forecast


EPS Forecast

$4 $5 $6 $7 $8 $9 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.29$4.51$5.08$5.47$6.03---
Avg Forecast$4.67$4.88$5.41$5.89$6.36$7.06$7.90$8.55
High Forecast$4.75$4.99$5.43$5.93$6.50$7.42$8.11$8.81
Low Forecast$4.59$4.77$5.39$5.88$6.20$6.37$7.51$8.26
Surprise %-8.14%-7.58%-6.10%-7.13%-5.19%---

Revenue Forecast

$8B $8B $9B $10B $11B $12B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.78B$8.08B$8.54B$9.26B$9.47B---
Avg Forecast$7.74B$8.04B$8.52B$9.26B$9.66B$10.33B$11.03B$11.44B
High Forecast$7.85B$8.18B$8.54B$9.27B$9.83B$10.35B$11.03B$11.71B
Low Forecast$7.65B$7.90B$8.50B$9.23B$9.45B$10.31B$11.03B$11.14B
Surprise %0.42%0.47%0.25%-0.05%-2.02%---

Net Income Forecast

$1B $2B $2B $3B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.04B$2.11B$2.34B$2.49B$2.67B---
Avg Forecast$1.77B$2.01B$2.34B$2.73B$2.94B$3.05B$3.61B$3.95B
High Forecast$2.12B$2.42B$2.81B$2.74B$3.01B$3.43B$3.75B$4.07B
Low Forecast$1.41B$1.61B$1.88B$2.72B$2.87B$2.94B$3.47B$3.82B
Surprise %15.25%5.02%--8.87%-8.99%---

ZTS Forecast FAQ


Is Zoetis stock a buy?

Zoetis stock has a consensus rating of Hold, based on 31 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 13 Buy, 17 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zoetis is a neutral investment for most analysts.

What is Zoetis's price target?

Zoetis's price target, set by 31 Wall Street analysts, averages $99.17 over the next 12 months. The price target range spans from $85 at the low end to $160 at the high end, suggesting a potential 34.83% change from the previous closing price of $73.55.

How does Zoetis stock forecast compare to its benchmarks?

Zoetis's stock forecast shows a 34.83% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (8.86%).

What is the breakdown of analyst ratings for Zoetis over the past three months?

  • August 2026: 15.00% Strong Buy, 40.00% Buy, 45.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 15.00% Strong Buy, 40.00% Buy, 45.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 15.00% Strong Buy, 40.00% Buy, 45.00% Hold, 0% Sell, 0% Strong Sell.

What is Zoetis’s EPS forecast?

Zoetis's average annual EPS forecast for its fiscal year ending in December 2026 is $7.06, marking a 17.08% increase from the reported $6.03 in 2025. Estimates for the following years are $7.9 in 2027, and $8.55 in 2028.

What is Zoetis’s revenue forecast?

Zoetis's average annual revenue forecast for its fiscal year ending in December 2026 is $10.33B, reflecting a 9.09% increase from the reported $9.47B in 2025. The forecast for 2027 is $11.03B, and $11.44B for 2028.

What is Zoetis’s net income forecast?

Zoetis's net income forecast for the fiscal year ending in December 2026 stands at $3.05B, representing an 13.94% increase from the reported $2.67B in 2025. Projections indicate $3.61B in 2027, and $3.95B in 2028.